FEATURED EDITORIAL
This attorney provides practical advice. Can artificial intelligence (AI) make drug discovery easier? Yes! Will we lose the human component essential to the innovation culture? No.
- The Search For A Chemotherapy-Free Treatment For Patients With Blood Cancer
- Bridge RNAs: Principles, Applications, And Challenges
- Is Your Lab Ready For A LIMS Implementation?
- Correct But Misleading: AI Hallucinations In Complex Decision-Making
- Harnessing The Power Of the Innate Immune System In Cancer Research
- ChatGPT-4: Practical Applications For The Biopharma Laboratory
- Discovering "Molecular Hallmarks" And "Master Regulators" In Epilepsy
FEATURED APPLICATION CONTENT
-
What steps is the biopharma industry taking to enhance sustainability? What challenges does biopharma encounter? And how can the entire industry draw lessons from the companies setting the standard?
-
A healthcare manufacturer facing space constraints and regulatory pressures outsourced their stability storage needs to another company, resulting in reduced costs and focus on core competencies.
-
When facing a malfunction, having an effective disaster recovery plan can make the difference between a swift fix, and losing your samples and time.
-
A pharmaceutical company facing storage space issues decided to outsource their reference samples to Q1 Scientific, a stability storage service provider, resulting in cost savings.
-
Partnering with a leader in outsourced stability storage is revolutionizing the pharmaceutical and medical device industry to ensure product quality and compliance.
-
Testing for nitrosamines - potential carcinogens present in food, beverages, cosmetics and pharmaceuticals - is vital in the creation of Active Pharmaceutical Ingredients (APIs) and drug products.
-
Explore the current challenges of developing gene therapies, the potential of Organ-on-a-Chip technology, the future of gene therapy, and more.
-
Explore critical considerations for biopharmaceutical developers and CDMOs during technology transfer as well as a successful transfer and scale-up of a cell line from a CLD platform to a global CDMO.
-
Explore a detailed process for validating ligand-binding assays, particularly for Fcγ receptor binding analytes or other structural isoforms.
-
This study showcases the performance of regenerated cellulose flat sheet membranes with a 100 kDa molecular weight cutoff for UF/DF of RNA molecules by TFF.
-
A common requirement for media and buffer preparation in biopharma processing is powder-liquid mixing. Review the performance of a 3000 L single-use mixing system for preparing aqueous solutions.
-
In designing a mixing process for scale-up, the power number is a critical parameter. Explore the determined power numbers for a single-use mixer at various mixing speeds and fill levels.
FEATURED NEWS HEADLINES
- Next-Generation TFF Cassette, Vivaflow® SU, Delivers Intuitive, Effortless, And Sustainable Ultrafiltration To Research Scientists
- ERS Genomics And Medicines Discovery Catapult Sign CRISPR/Cas9 License Agreement
- HAYA Therapeutics Announces Collaboration With Lilly To Discover Novel Regulatory Genome Targets For Obesity And Related Metabolic Conditions Using Proprietary RNA Platform
- BioVie Announces FDA Authorization Of Investigational New Drug Application For Phase 2 Trial To Evaluate Bezisterim In Long COVID
- Arcturus Therapeutics Receives Clearance Of An Investigational New Drug Application To U.S. Food And Drug Administration For ARCT-032, An Investigational Inhaled mRNA Therapeutic To Treat Cystic Fibrosis
- Obsidian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation For OBX-115 For The Treatment Of Advanced Melanoma
- QSimulate And Japan Tobacco Announce Strategic Partnership To Accelerate Small Molecule Drug Discovery Technologies
- Exploring Peptide Clumping For Improved Drug And Material Solutions
- Unicycive Therapeutics Announces Submission Of The New Drug Application (NDA) To The U.S. FDA For Oxylanthanum Carbonate (OLC) For The Treatment Of Hyperphosphatemia In Patients With Chronic Kidney Disease On Dialysis
- Syntekabio Collaborates With Global Compound Supplier Enamine For AI-Based Synthetic Drug Development
ARCHIVED NEWSLETTER
- 09.11.24 -- All Eyes On Sustainability
- 09.10.24 -- Bridge RNAs: Principles, Applications, And Challenges
- 09.06.24 -- Connect With Top CDMOs And Access Solutions Tailored To Your Needs
- 09.04.24 -- Connect With Top CDMOs And Access Solutions Tailored To Your Needs
- 09.03.24 -- Is Your Lab Ready For A LIMS Implementation?